Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor models-Reference-Cited by-同舟云学术

Tumor disposition of pegylated liposomal CKD-602 and the reticuloendothelial system in preclinical tumor models

Published:2010-06-09 Issue:1 Volume:21 Page:70-80
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Zamboni William C.,Eiseman Julie L.,Strychor Sandra,Rice Patricia M.,Joseph Erin,Zamboni Beth A.,Donnelly Mark K.,Shurer Jennifer,Parise Robert A.,Tonda Margaret E.,Yu Ning Y.,Basse Per H.

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

http://www.tandfonline.com/doi/pdf/10.3109/08982101003754385

Reference33 articles.

1. Macrophages of the Splenic Marginal Zone Are Essential for Trapping of Blood-Borne Particulate Antigen but Dispensable for Induction of Specific T Cell Responses

2. Advantages of liposomal delivery systems for anthracyclines

3. Cancer Immunotherapy with Interleukin-2-Activated Natural Killer Cells

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-based delivery systems to overcome drug resistance in cancer;Medical Review;2024-02-01

2. Revisiting the outstanding questions in cancer nanomedicine with a future outlook;Nanoscale Advances;2022

3. Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment;Journal of Personalized Medicine;2021-06-18

4. Imaging methods to evaluate tumor microenvironment factors affecting nanoparticle drug delivery and antitumor response;Cancer Drug Resistance;2021

5. Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model;Therapeutic Advances in Medical Oncology;2021-01